Furthermore, ESCO2 promotes the formation of 53BP1 foci to DSB sites by stabilizing cohesin complex and is essential for resistance to chemotherapy in colorectal cancer cells (CRC). This evidence concerns the gene TP53BP1 and colorectal carcinoma.